Novo Seeds is a capital investment and private equity firm that is interested in biotechnology sectors that deliver healthcare applications. The firm was founded in 2007, in Hallerup, Hovedstaden, Denmark.
The firm is interested in companies that develop drugs for illnesses, molecules that interact with disease-causing modalities, biotechnology, protein interactions, and proprietary platforms. The firm has made a total of nineteen investments, with notable exits including Galecto Biotech and Lysogene. The firm invests during Series B and venture rounds.
Syndesi Therapeutics is a company developing molecules for the treatment of cognitive disorders of various neurological conditions.
Documentaries, videos and podcasts
- Venture capitalA form of financing or funding for emerging companies. Investment on early-stage companies in exchange for equity in the companies they invest in.
- Private equity firmInvestment manager that makes investments in the private equity of operating companies
- Private equityPrivate equity is a non-publicly traded source of capital from investors who seek to invest or acquire equity ownership in a company.